Aethlon Medical (AEMD) Reports Q2 Loss of $0.14
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 11/4/2026
- Wall Street rises after Democrats win Congress; data center stocks tumble
- What the Democratic sweep in the midterms means for markets
- SpaceX, Tesla slide as election risks mount, Morgan Stanley turns bullish
- CVS Health plans to split into two public companies by 2028
- AI sector outlook darkens as Democrat wins threaten $900B capex cycle
Tweet
Share
E-mailGet Alerts AEMD Hot Sheet
Price: $5.88 +1.38%
Financial Fact:
Loss on extinguishment of debt: 0
Today's EPS Names:
ATS, SICP, FTCO, More
Financial Fact:
Loss on extinguishment of debt: 0
Today's EPS Names:
ATS, SICP, FTCO, More
Join SI Premium – FREE
Aethlon Medical (NASDAQ: AEMD) reported Q2 EPS of ($0.14), versus ($0.29) reported last year.
For earnings history and earnings-related data on Aethlon Medical (AEMD) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- MFA Financial (MFA) Misses Q3 EPS by 2c
- Marriott Vacations Worldwide (VAC) Tops Q3 EPS by 7c; offers guidance
- Reservoir Media, Inc. (RSVR) Tops Q2 EPS by 2c; offers guidance
Create E-mail Alert Related Categories
Earnings, GuidanceRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
